Palmitoyl Tetrapeptide-7/Palmitoyl Tetrapeptide-3/Drug peptide

Introduction from Drug peptide supply about:Palmitoyl Tetrapeptide-7/Palmitoyl Tetrapeptide-3/221227-05-0

Introduction of Palmitoyl Tetrapeptide-7

Palmitoyl tetrapeptide-7 is primarily used in anti-aging products due to its ability to lighten the skin and improve skin elasticity. Here are some of the important benefits the chemical provides that make it a common ingredient in anti-aging skin care products: The chemical, found in high concentrations in beauty products, may reduce interleukin production by as much as 40 percent. Interleukin is a chemical often associated with inflammation because the body makes interleukins when it is damaged. For example, skin cells damaged by overexposure to UV light can cause the production of this chemical, which can cause the cells to deteriorate due to inflammation. By blocking this chemical, palmitoyl tetrapeptide 7 relieves certain chemical stress on the skin and allows it to recover faster.
Palmitoyl tetrapeptide-7 also reduces rough skin, fine lines, thin skin, and wrinkles.
Appropriate proportions of palmitoyl tetrapeptide-7 and palmitoyl oligopeptide in cosmetic products induce natural collagen production to restore skin health.
May help treat rosacea and reduce the appearance of uneven skin tone.

The mechanism of action of palmitoyl tetrapeptide-7

Palmitoyl tetrapeptide-7 is a partial fragment that mimics immunoglobulin IgG. It acts on keratinocytes and fibroblasts through signal stimulation, which can delay and inhibit the release of excess inflammatory factor leukocyte mediator IL-6, thereby inhibiting inappropriate inflammatory responses. and glycosylation damage, maintain the balance of cytokines in the skin to achieve protection of the skin, thereby reducing wrinkles and firming the skin. Modification with the palmitoyl group improves the stability and transdermal absorption rate of the peptide. Palmitoyl tetrapeptide-7 can be used in combination with other peptides and has a synergistic effect.

How Palmitoyl Tetrapeptide-7 Inhibits Interleukin

Palmitoyl Tetrapeptide-7 has been clinically shown to inhibit the body’s production of interleukin (IL6), a chemical messenger that triggers inflammation, the first step in the aging process. Inflammation is an immune function, a protective response to tissue damage or destruction. This is how the body isolates harmful substances and injured tissue. Under normal conditions, IL6 is rarely secreted and its secretion is tightly controlled. However, with age, this regulatory system becomes defective and large amounts of IL6 are present in plasma even in the absence of inflammatory stimulation. This results in high levels of inflammatory proteins in the tissue and loss of healing potential. At a concentration of 10 ppm, palmitoyl tetrapeptide 3 induced a marked decrease in the secretion of the cytokine IL6. This reduction was progressive and dependent on peptide concentration: baseline secretion was inhibited by up to 40%. Exposure of cells to UV radiation by palmitoyl tetrapeptide-7 reduced IL6 levels by as much as 86%, even though IL6 had been increased by about 20-fold by UV light. These results suggest that palmitoyl tetrapeptide-3 is able to affect baseline levels of IL6 and modulate the effects of UV-stimulated IL6 overproduction. Exposure of cells to UV radiation by palmitoyl tetrapeptide-7 reduced IL6 levels by as much as 86%, even though IL6 had been increased by about 20-fold by UV light. These results suggest that palmitoyl tetrapeptide-7 is able to affect baseline levels of IL6 and modulate the effects of UV-stimulated IL6 overproduction.

How to buy Palmitoyl Tetrapeptide-7 in the U. S.

Remetide Peptide Supplier specializes in the production and sales of peptides in the USA, as well as Professional Drug peptide R&D. Feel free to contact us if you have any questions or inquiries about Palmitoyl Tetrapeptide-7 Peptides.

Hot line:+19498788363

Wechat:americhina

Email:amin@remetide.com